8 unknown. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Unknown 8 |
Follow Aprepitant: new trials by email Literature Review of Aprepitant trials Research Report on Aprepitant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting Aprepitant Injection, Aprepitant Injection Placebo - Post-operative Nausea and Vomiting (PONV) | Phase 3 | Unknown | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 486 | 2024-10-28 | 2024-08-09 |
| Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC Aprepitant in combination with granisetron and dexamethasone, Granisetron and dexamethasone - Hepatocellular Carcinoma | Phase 3 | Unknown | Guangxi Medical University | 300 | 2024-07-01 | 2024-01-23 |
| Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents Ondansetron, Dexamethasone, Aprepitant - Chemotherapy-induced Nausea and Vomiting | Phase 3 | Unknown | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 210 | 2022-04-01 | 2022-07-28 |
| Granisetron Transdermal Patch for Prophylaxis of Delayed CINV Granisetron transdermal patch, Palonosetron, Aprepitant - Chemotherapy-induced Nausea and Vomiting (CINV) | Phase 3 | Unknown | Fudan University | 140 | 2021-06-10 | 2021-06-03 |
| Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic Chemotherapy aprepitant, olanzapine 10 mg, olanzapine 5 mg - Antiemetic for Highly Emetogenic Chemotherapy | Phase 3 | Unknown | Mahidol University | 147 | 2019-03-01 | 2019-03-15 |
| Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy Aprepitant, Ondansetron, Metoclopramide - Chemotherapy Induced Vomiting, Acute Myeloid Leukemia | Phase 3 | Unknown | Dr Atul Sharma | 116 | 2016-11-01 | 2017-01-25 |
| Aprepitant for Prevention of Acute and Delayed Nausea and Vomiting in Patients Receiving a High-emetogenic Dose of Cyclophosphamide for Peripheral Blood Stem Cells Harvesting Aprepitant, Palonosetron, Dexamethasone, Placebo, Palonosetron, Dexamethasone - Nausea, Vomiting | Phase 3 | Unknown | Azienda Ospedaliera di Perugia | 120 | 2010-04-01 | 2010-03-17 |
| Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy Emend, Placebo - Multiple Myeloma | Phase 3 | Unknown | Heidelberg University | 362 | 2005-07-01 | 2010-01-12 |
Vomiting (5) · Carcinoma, Hepatocellular (1) · Leukemia, Myeloid, Acute (1) · Multiple Myeloma (1) · Nausea (1)
Azienda Ospedaliera di Perugia (1) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (1) · Dr Atul Sharma (1) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) · Fudan University (1) · Guangxi Medical University (1) · Heidelberg University (1) · Mahidol University (1)
Germany (1) · India (1) · Italy (1) · Russia (1) · Thailand (1)
Gerlinde Egerer, MD (1) · Le-Qun Li (1) · Leonardo Flenghi, M.D. (1) · Suthinee Ithimakin, MD (1)